USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-02-29 обновлены отчеты компании CLBS: 20232022
Caladrius Biosciences logo
Caladrius Biosciences CLBS
$ 0.43 -16.75%

Caladrius Biosciences Мультипликаторы 2011-2024 | CLBS

Мультипликаторы по годам Caladrius Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.2 -0.0 -0.1 -4.0 -1.6 -2.9 1.7 -0.8 -0.3 -2.1 -3.9 -1.6 -1.1

P/S

- - - - - - - 0.8 1.2 6.5 10.4 6.2 0.7

EPS

-2.6 -10.5 -7.5 -0.5 -1.9 -1.7 2.6 -5.0 -1.7 -1.7 -1.9 -0.4 -0.5

EV (Enterprise Value)

-12.3 млн -23.2 млн -17.1 млн 20 млн 23.3 млн 43.8 млн 22.1 млн 60.5 млн 40.3 млн 165 млн 134 млн 96 млн 125 млн

EBITDA per Share

-3.16 -11.1 -7.86 -1.24 -1.94 -1.73 -3.04 -4.37 -10.1 -17 -17.2 -20.8 -29.5

EV/EBITDA

0.7 -0.9 -0.8 -2.2 -0.3 -0.7 -0.5 -2.0 -3.1 -2.7 -2.2

PEG

-0.0 -0.0 -0.0 -0.06 0.13 0.02 0.01 -0.01 -0.55 -0.18 -0.07 -0.06 0.07

P/B

0.1 0.0 0.0 1.0 1.5 1.3 0.8 6.7 1.1 2.0 2.5 2.7 0.7

P/CF

-0.2 -0.1 -0.1 -3.7 -1.6 -2.3 -1.8 -1.0 -0.6 -2.3 -5.1 -6.1 -2.0

ROE %

-43.28 -81.45 -29.77 -25.28 -94.20 -43.16 45.78 -803.06 -347.39 -94.49 -62.85 -163.83 -58.82

ROA %

-38.10 -74.25 -28.31 -22.64 -71.30 -36.27 36.26 -63.00 -141.40 -43.45 -43.40 -98.83 -30.35

ROCE %

-53.39 -86.52 -31.49 -58.91 -94.88 -43.60 -51.04 -96.92 -142.51 -52.48 -46.01 -68.35 -29.53

Current Ratio

8.0 10.9 19.4 10.1 4.3 7.8 6.6 1.3 1.4 2.2 5.2 1.7 1.1

DSO

- - - - - - - 29.9 41.7 63.3 46.3 26.8 32.4

DIO

- - - - - - - - - - 35.8 34.0 111.9

DPO

- - - - - - - 51.2 74.4 131.8 94.6 78.1 67.9

Операционный цикл

- - - - - - - 29.9 41.7 63.3 82.1 60.8 144.2

Финансовый цикл

- - - - - - - -21.3 -32.7 -68.5 -12.5 -17.2 76.3

Все данные представлены в валюте USD

Мультипликаторы поквартально Caladrius Biosciences

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.65 -0.5 -0.77 - -7.88 -1.64 -1.05 - -1.74 -0.1 -0.19 - -0.29 0.5 -0.38 - -0.47 -0.49 -0.44 - -0.36 -0.42 -0.52 - -0.38 4.34 -1.12 - -1.09 -1.33 -2.09 -0.59 -2.06 -3.84 -0.51 -0.32 -0.48 -0.4 -0.49 -0.47 -0.45 -0.46 -0.53 - -0.64 -1.53 -0.08 - -0.08 -0.13 -0.14

EBITDA per Share

-0.73 -0.85 -0.85 - -7.94 -1.66 -1.64 - -1.74 -0.12 -0.19 - -0.29 -0.32 -0.38 - -0.48 -0.51 -0.46 - -0.36 -0.43 -0.53 - -0.64 -0.84 -0.69 - -0.85 -1.21 -1.8 - -1.54 -5.48 -0.47 - -0.42 -0.36 -0.46 - -0.4 -0.4 -0.3 - -0.42 -0.37 -0.04 - -0.05 -0.08 -0.04

ROE %

-79.12 -121.27 -122.39 -64.94 -71.98 -26.93 -24.28 -19.77 -36.16 -45.51 -19.79 -8.37 -31.90 -39.03 -84.03 -69.20 -78.61 -64.49 -50.60 -33.43 -40.45 -38.07 48.90 49.74 -99.47 -241.67 -479.27 -557.34 -557.48 -408.32 -246.94 -0.34 -0.22 -0.20 -0.15 -0.09 -0.09 -0.08 -0.07 -0.06 -25.39 -50.73 -112.52 -115.33 -127.18 -113.67 -68.96 -45.34 -11.84 -17.10 -16.40

ROA %

-72.45 -110.99 -109.16 -56.84 -63.60 -18.13 -23.36 -19.02 -33.82 -41.86 -18.30 -7.55 -25.59 -28.83 -66.09 -53.05 -61.01 -50.93 -41.15 -28.29 -33.88 -31.52 38.32 39.64 26.02 18.00 -57.42 -51.60 -51.65 -38.06 -23.35 -0.14 -0.09 -0.09 -0.07 -0.04 -0.05 -0.04 -0.04 -0.04 -15.49 -30.94 -68.62 -70.33 -75.06 -64.33 -33.47 -18.11 -4.73 -6.83 -6.55

ROCE %

-52.56 -105.11 -113.29 -68.24 -75.32 -29.84 -28.47 -21.22 -37.69 -47.07 -53.47 -42.16 -66.52 -74.42 -86.90 -72.11 -82.08 -67.69 -53.32 -34.97 -47.10 -49.26 -53.21 -40.14 -157.41 -262.55 -398.92 -495.64 -539.43 -465.94 -422.55 -228.31 -256.09 -240.09 -153.09 -64.75 -77.14 -61.75 -51.43 -33.09 -51.14 -56.80 -61.08 -50.08 -57.61 -47.10 -42.36 -25.37 -7.53 -10.46 -7.37

Current Ratio

10.8 13.4 11.8 10.9 11.6 - 28.4 19.4 24.9 27.6 24.9 9.6 9.6 9.6 9.6 4.1 4.1 4.1 4.1 6.3 6.3 6.3 6.3 4.8 4.8 4.8 4.8 1.8 1.8 1.8 1.8 1.7 0.9 1.7 1.7 1.9 1.8 1.9 1.9 3.2 - 3.2 - - - - - - - - -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - 19.1 - 1.4 16.7 33.2 30973.1 39.8 39.9 81.7 53810.4 69.0 63.2 55.9 41638.3 45.8 39.0 52.7 - 21.7 28.5 18.2 - 42.4 155.7 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 47.5 43.5 32.8 - 27.6 27.4 45.5 - 27.1 37.1 27.2 - 31.2 453.6 -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - 20.2 - 23.6 42.7 62.1 - 77.9 64.6 132.3 - 128.8 140.5 107.5 - 102.9 72.3 112.7 - 62.2 85.2 74.8 - 110.3 319.1 -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - 19.1 - 1.4 16.7 33.2 30973.1 39.8 39.9 81.7 53810.4 116.4 106.8 88.7 41638.3 73.4 66.3 98.1 - 48.8 65.6 45.4 - 73.6 609.3 -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - -1.2 - -22.2 -26.0 -28.8 30973.1 -38.2 -24.7 -50.7 53810.4 -12.3 -33.7 -18.8 41638.3 -29.5 -6.0 -14.6 - -13.4 -19.6 -29.4 - -36.8 290.2 -

Все данные представлены в валюте USD